Cargando…

Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer

Background: Lung cancer is associated with a high mortality rate and often complicated with malignant pleural effusion (MPE), which has a very poor clinical outcome with a short life expectancy. However, our understanding of cell-specific mechanisms underlying the pathobiology of pleural metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yu-Yuan, Hsu, Ya-Ling, Huang, Yung-Chi, Su, Yue-Chiu, Wu, Kuan-Li, Chang, Chao-Yuan, Ong, Chai-Tung, Lai, Jia-Chen, Shen, Tzu-Yen, Lee, Tai-Huang, Hung, Jen-Yu, Tsai, Ying-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465223/ https://www.ncbi.nlm.nih.gov/pubmed/37649596 http://dx.doi.org/10.7150/thno.85084

Ejemplares similares

Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer
por: Huang, Yung-Chi, et al.
Publicado: (2022)

miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells
por: Chang, Wei-An, et al.
Publicado: (2021)

Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming
por: Wu, Kuan-Li, et al.
Publicado: (2022)

The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion
por: Chen, Ke-Cheng, et al.
Publicado: (2021)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction
por: Wu, Shang-Gin, et al.
Publicado: (2011)

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
por: Lee, Hsiao-Chen, et al.
Publicado: (2022)

EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function
por: Huang, Ching-Wen, et al.
Publicado: (2017)

Alterations by Air Pollution in Inflammation and Metals in Pleural Effusion of Pneumonia Patients
por: Bai, Kuan-Jen, et al.
Publicado: (2019)

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
por: Liu, Yi-Nan, et al.
Publicado: (2015)

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
por: Tsai, Yu-Chen, et al.
Publicado: (2021)

Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche
por: Han, Peng, et al.
Publicado: (2020)

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
por: Kuo, Chia-Yu, et al.
Publicado: (2022)

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study
por: Chen, Yung-Hsuan, et al.
Publicado: (2019)

Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis
por: Lee, Tai-Huang, et al.
Publicado: (2022)

Sulforaphane attenuates EGFR signaling in NSCLC cells
por: Chen, Chi-Yuan, et al.
Publicado: (2015)

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
por: Tsai, Ming-Ju, et al.
Publicado: (2023)

BMVC test, an improved fluorescence assay for detection of malignant pleural effusions
por: Lin, I-Ting, et al.
Publicado: (2014)

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
por: Weng, Chao-Yuan, et al.
Publicado: (2021)

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
por: Tsai, Ying-Ming, et al.
Publicado: (2020)

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
por: Wu, Chung-Pu, et al.
Publicado: (2023)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
por: Tsai, Meng-Feng, et al.
Publicado: (2015)

Hydroxygenkwanin Suppresses Non-Small Cell Lung Cancer Progression by Enhancing EGFR Degradation
por: Leu, Yann-Lii, et al.
Publicado: (2020)

Concurrent Blockade of Endothelial EGFR and VEGF Signaling on Malignant Associated Pleural Fluid Induced Angiogenesis: From Clinic to Bench
por: Chen, Wei-Teing, et al.
Publicado: (2021)

Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration
por: Chen, Chih-Lung, et al.
Publicado: (2020)

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer
por: Tsai, Ying-Ming, et al.
Publicado: (2021)

A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer
por: Chen, Mao-Lin, et al.
Publicado: (2022)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

(18)F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line EGFR-TKIs
por: Huang, Yu-Erh, et al.
Publicado: (2022)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
por: Varas-Godoy, Manuel, et al.
Publicado: (2017)

Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation
por: Tsai, Chen-Liang, et al.
Publicado: (2022)

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
por: Chang, Chao-Yuan, et al.
Publicado: (2021)

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors
por: Huang, Chun-Ta, et al.
Publicado: (2023)

ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade
por: Tsai, Yu-Ting, et al.
Publicado: (2019)

Helical Tomotherapy Combined with Capecitabine in the Preoperative Treatment of Locally Advanced Rectal Cancer
por: Huang, Ming-Yii, et al.
Publicado: (2014)

Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody
por: Lin, Yu-Wei, et al.
Publicado: (2022)

Stem Cell Niche Microenvironment: Review
por: Abdul-Al, Mohamed, et al.
Publicado: (2021)

Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization
por: Wang, Tong-Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rfp4upigvb4ktnijubchoohq51